FDA grants iStar Medical IDE for glaucoma implant pivotal trial
iSTAR Medical announced today that the FDA granted investigational device exemption to start a pivotal trial […]
iSTAR Medical announced today that the FDA granted investigational device exemption to start a pivotal trial with its MINIject implant.
Wavre, Belgium-based iStar’s MINIject minimally invasive implant for glaucoma surgery will be investigated in the STAR-V study, which will enroll over 350 patients with primary open-angle glaucoma.
Original article: (https://www.massdevice.com/fda-grants-istar-medical-ide-for-glaucoma-implant-pivotal-trial/)
